ผู้เขียน: admin
-
CityUHK (Dongguan) Hosts Inaugural Commencement 2026 at CityUHK
HONG KONG, June 22, 2026 /PRNewswire/ — City Universit…
-
AS Watson Launches brand lab to Turn Retail Scale into a Data-driven Brand Growth Engine
HONG KONG SAR – Media OutReach Newswire – 22 June 2026 …
-
Biomerics Appoints Kristin Mason as Chief Financial Officer
SALT LAKE CITY, June 22, 2026 /PRNewswire/ — Biomerics…
-
ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts
HONG KONG, June 22, 2026 /PRNewswire/ — ACEMATE today …
-
Prime Day Exclusive Meets July 4th Launch: Glocusent Unveils Camping Lanterns with Its Biggest Sale of the Year
DENVER, June 22, 2026 /PRNewswire/ — As the 2026 campi…
-
AMTD Group and AMTD IDEA Reaffirm Long-Term Commitment to TGE with a Two-Year Voluntary Lock-Up
PARIS, LONDON and NEW YORK, June 22, 2026 /PRNewswire/ …
-
HOMRELEXA Brings Comfort-Driven, Multi-Use Office Chair to Prime Day 2026
NEW YORK, June 22, 2026 /PRNewswire/ — As Prime Day 20…
-
The Container Arrived. The Real Test Had Just Begun. ChinaMarket’s Global Journey
LINYI, China, June 22, 2026 /PRNewswire/ — In cross-bo…
-
Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)
European approval is based on results from the Phase 3 …
-
NYSE Content Update: Cannes Lions International Festival of Creativity Begins
NYSE issues a pre-market daily advisory direct from the…